In a first-of-its-kind initiative at the summit, cardiac specialists had the opportunity to experience hands-on simulations of current, upcoming innovative therapies and technologies for the treatment of cardiovascular diseases at Innovation Village on the occasion of Medtronic hosted Medical Device Summit in New Delhi recently.

Medtronic, the global leader in medical technology, designed the Innovation Village with the objective of giving clinicians a look at future technologies and products under development that can address barriers to healthcare access in India while providing technologies with strong clinical evidence.

Disease conditions examined included bradycardia (slow heart rhythm), aortic stenosis (heart valve defect), coronary artery bypass graft surgery (bypass surgery), peripheral artery disease and angioplasty in patients with diabetes.

The summit addressed some of the key issues concerning Cardiac Care in India such as the need for standard treatment guidelines, skilled practitioners, advanced infrastructure and technology as a solution for improving patient outcomes and increasing access.

For the second year in a row, Medtronic hosted the Medical Device Summit, bringing together leading national and international healthcare practitioners, research scientists, and business leaders.  The theme of this year’s Summit was “Technological Innovation,” and speakers shared their views and latest updates on innovation and clinical outcomes driving the evolution of the healthcare ecosystem.

The Innovation Village was attended by more than 250 cardiologists from different parts of the country and leading medical institutions. Dr Jagdish Prasad, Director General of Health Services, Ministry of Health and Family Welfare, was the guest of honor at the summit.

Referring to Innovation Village, Bob White, senior vice president and president, Asia Pacific, Medtronic said, “Medtronic is committed to accelerating the development of therapy innovations for patients with chronic diseases to broaden access and improve outcomes with measurable economic value. In addition to the depth and breadth of our product portfolio, we are developing services and solutions that will help to transform healthcare. The Innovation Village created an environment conducive to group collaboration and productive exchange of ideas with the goal of taking healthcare further, together.”

Dr. Atul Mathur, director, Interventional Cardiology, Escorts Heart Institute and Research Center, New Delhi, who convened a workshop at the Innovation Village, said, “Opportunities that give clinicians a chance to update their knowledge through practical, hands-on exposure to new, cutting-edge technologies and products under development motivate them to manage their cases more effectively. The Innovation Village was an excellent way for us to examine up close the life-saving devices that are being used to treat cardiovascular disease around the world.”

Speaking at the Innovation Village, Shamik Dasgupta, vice president of the Cardiac and Vascular Group for Medtronic in South Asia said, “True to our Mission to alleviate pain, restore health and extend life, everything we do is consistent with delivering the best possible care for patients. For Medtronic, innovation and clinical outcomes go hand in hand and we actively work towards managing and demonstrating the outcomes by driving product quality and safety initiatives through the processes of product development, manufacturing, supplier quality assessments, clinical trials, post-market surveillance activities, and customer satisfaction surveys.”

Medtronic plc headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies.